1
Jochems, A., Bastiaannet, E., Aarts, M.J.B., van Akkooi, A.C.J., van den Berkmortel, F.W.P.J., Boers-Sonderen, M.J., van den Eertwegh, A.J.M., de Glas, N.G., de Groot, J.W.B., Haanen, J.B.A.G., Hospers, G.A.P., van der Hoeven, J.J.M., Piersma, D., van Rijn, R.S., Suijkerbuijk, K.P.M., ten Tije, A.J., van der Veldt, A.A.M., Vreugdenhil, G., van Zeijl, M.C.T., Kapiteijn, E., Wouters, M.W.J.M.
Veröffentlicht in: Jochems , A , Bastiaannet , E , Aarts , M J B , van Akkooi , A C J , van den Berkmortel , F W P J , Boers-Sonderen , M J , van den Eertwegh , A J M , de Glas , N G , de Groot , J W B , Haanen , J B A G , Hospers , G A P , van der Hoeven , J J M , Piersma , D , van Rijn , R S , Suijkerbuijk , K P M , ten Tije , A J , van der Veldt , A A M , Vreugdenhil , G , van Zeijl , M C T , Kapiteijn , E & Wouters , M W J M 2021 , ' Outcomes for systemic therapy in older patients with metastatic melanoma: Results from the Dutch Melanoma Treatment Registry ' , Journal of Geriatric Oncology , vol. 12 , no. 7 , pp. 1031-1038 . https://doi.org/10.1016/j.jgo.2021.04.006;
2021
Veröffentlicht in: Jochems , A , Bastiaannet , E , Aarts , M J B , van Akkooi , A C J , van den Berkmortel , F W P J , Boers-Sonderen , M J , van den Eertwegh , A J M , de Glas , N G , de Groot , J W B , Haanen , J B A G , Hospers , G A P , van der Hoeven , J J M , Piersma , D , van Rijn , R S , Suijkerbuijk , K P M , ten Tije , A J , van der Veldt , A A M , Vreugdenhil , G , van Zeijl , M C T , Kapiteijn , E & Wouters , M W J M 2021 , ' Outcomes for systemic therapy in older patients with metastatic melanoma: Results from the Dutch Melanoma Treatment Registry ' , Journal of Geriatric Oncology , vol. 12 , no. 7 , pp. 1031-1038 . https://doi.org/10.1016/j.jgo.2021.04.006;
2021
2
Ten Berge, Deirdre M H J, Aarts, Mieke J, Groen, Harry J M, Aerts, Joachim G J V, Kloover, Jeroen S
Veröffentlicht in: Ten Berge , D M H J , Aarts , M J , Groen , H J M , Aerts , J G J V & Kloover , J S 2022 , ' A population-based study describing characteristics, survival and the effect of TKI treatment on patients with EGFR mutated stage IV NSCLC in the Netherlands ' , European Journal of Cancer , vol. 165 , pp. 195-204 . https://doi.org/10.1016/j.ejca.2022.01.038;
2022
Veröffentlicht in: Ten Berge , D M H J , Aarts , M J , Groen , H J M , Aerts , J G J V & Kloover , J S 2022 , ' A population-based study describing characteristics, survival and the effect of TKI treatment on patients with EGFR mutated stage IV NSCLC in the Netherlands ' , European Journal of Cancer , vol. 165 , pp. 195-204 . https://doi.org/10.1016/j.ejca.2022.01.038;
2022